| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.0039 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |